Skip to content

Efficacy of synbiotics in old patients with irritable bowel syndrome

Efficacy of synbiotics in old patients with irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0005449
Enrollment
68
Registered
2020-10-07
Start date
2019-09-03
Completion date
Unknown
Last updated
2020-11-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Elderly patients (60 years or older) who met the Rome IV criteria (at least 1 day per week in the last 3 months) for the diagnosis of IBS were eligible to participate.

Exclusion criteria

Exclusion criteria: The exclusion criteria were previous abdominal surgery except appendectomy and Caesarian section, inflammatory bowel syndrome, and concurrent severe illness (cancer, cardiovascular or pulmonary disease). In addition, patients who had used antipsychotics, antibiotics, and probiotics within the two weeks were also excluded.

Design outcomes

Primary

MeasureTime frame
Subjective global assessment;Visual analogue scale

Secondary

MeasureTime frame
Bristol stool chart

Countries

Korea, Republic of

Contacts

Public ContactYANG WON MIN

Samsung Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026